Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 78 records per page: next > | last >>
pages: 1 2 3 4 5 ... 75 76 77 78 presentations: 1 to 25 of 1933
Controversies in Replication ctDNA Measurements
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
  •  
  • Permission not
    granted for presentation
  •  
  •  
Cancer therapeutics: A view from the microbiota
Christian Jobin
Univ. of Florida, Gainesville, FL, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Dynamic monitoring of the dysbiotic microbiome
Jonathan Braun
Mt. Sinai Medical Center, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Identification and targeting microbial vulnerabilities
Ami S Bhatt
Stanford Medical School, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Encapsulated fecal transplant: It's not just for Clostridium difficile any more!
Elizabeth L Hohmann
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Intersection of Radiation and Immune Therapy
Clinical experience with radiotherapy in the context of immune checkpoint blockade
Michael A. Postow
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Intersection of Radiation and Immune Therapy
Effects of radiation on tumor antigenicity and adjuvanticity: From mouse to human
Sandra Demaria
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Intersection of Radiation and Immune Therapy
Interplay of DDR-targeting agents and oncolytic viruses with radiotherapy
Kevin J Harrington
The Institute of Cancer Research, London, United Kingdom
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Intersection of Radiation and Immune Therapy
Using smart materials to enhance in situ vaccination by radiation
Wilfred Ngwa
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 5:15 PM-7:15 PM
Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Discovery of BLU-667 for RET driven cancers
Jason Brubaker
Blueprint Medicines, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
Discovery and development of USP7 inhibitors
Tim Harrison
Almac Discovery, Belfast, Ireland
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
  •  
  • Permission not
    granted for presentation
  •  
  •  
Identification and optimization of chemical series that lead to discovery of erdafitinib: A potent pan-fibroblast growth factor receptor (FGFR) inhibitor
Patrick Angibaud
Janssen R & D, Val-de-Reuil, France
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Chemistry to the Clinic: Part 1: Lead Optimization in Cancer Drug Discovery
Development of potent and selective CD73 inhibitors: Discovery and characterization of AB680
Jenna Jeffrey
Arcus Biosciences, Inc., Hayward, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Coevolution of Tumor and Microenvironment in Cancer Metastasis
Systems Immunology and tumor microenvironment: Novel perspectives
Jérôme Galon
INSERM UMRS1138 - Cordeliers Research Ctr., Paris, France
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Coevolution of Tumor and Microenvironment in Cancer Metastasis
Blocking the heterotypic interactions of tumor and TME to control late stage cancer
Dihua Yu
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Coevolution of Tumor and Microenvironment in Cancer Metastasis
  •  
  • Permission not
    granted for presentation
  •  
  •  
Exploring the metastatic niche
Ilaria Malanchi
The Francis Crick Institute, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Coevolution of Tumor and Microenvironment in Cancer Metastasis
Mechanisms underlying polyclonal metastases
Kornelia Polyak
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Stromal Niches for Organ-Tropic Metastasis
Systemic consequences of the tumor-bone microenvironment: Implications for therapy
Theresa A Guise
Indiana Univ. School of Medicine, Indianapolis, IN, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Stromal Niches for Organ-Tropic Metastasis
A stromal gene program drives metastasis and immune evasion in colorectal cancer
Eduard Batlle Gomez
Inst. for Research in Biomedicine, Barcelona, Spain
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Stromal Niches for Organ-Tropic Metastasis
Reactive neutrophils in the immunosuppressive metastatic microenvironment
Xin Lu
Univ. of Notre Dame, Notre Dame, IN, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Stromal Niches for Organ-Tropic Metastasis
Stromal niches for bone metastasis
Yibin Kang
Princeton Univ., Princeton, NJ, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
Chairperson
Gabriele Bergers
VIB-Center of Cancer Biology, Leuven, Belgium
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
<< first | < prev page: of 78 records per page: next > | last >>
pages: 1 2 3 4 5 ... 75 76 77 78 presentations: 1 to 25 of 1933